Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Maggi

Showing results (441-450 of 469) with videos related to

Pageof 47
Sort By:
Frontiers in Cellular Neuroscience|November 23, 2017
Young Human Cholinergic Neurons Respond to Physiological Regulators and Improve Cognitive Symptoms in an Animal Model of Alzheimer's DiseaseAnnamaria Morelli, Erica Sarchielli, Giulia Guarnieri, et al.
Andrology|June 30, 2022
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohortRavinder Anand-Ivell, Kee Heng, Katie Severn, et al.
Plos One|July 19, 2012
Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetesGiovanni Di Pasquale, Ilaria Dicembrini, Laura Raimondi, et al.
Endocrinology|November 28, 2020
Insight on the Intracrinology of Menopause: Androgen Production within the Human VaginaIlaria Cellai, Vincenza Di Stasi, Paolo Comeglio, et al.
Reviews in Endocrine & Metabolic Disorders|June 3, 2024
Evidence-based definition of hypoprolactinemia in European men aged 40-86 years: the European male ageing studyThang S Han, Leen Antonio, György Bartfai, et al.
BJU International|July 14, 2016
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in MenFrans M J Debruyne, Hermann M Behre, Claus G Roehrborn, et al.
Molecular and Cellular Endocrinology|January 26, 2016
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbitsElena Maneschi, Ilaria Cellai, Antonio Aversa, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 6, 2023
Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European menNadjia Amini, Jolan Dupont, Laurence Lapauw, et al.
The Journal of Sexual Medicine|December 19, 2013
Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS)Giovanni Corona, Frederick C Wu, Giulia Rastrelli, et al.
The Journal of Sexual Medicine|July 3, 2009
The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunctionEmmanuele A Jannini, Andrea M Isidori, Giovanni Luca Gravina, et al.
Pageof 47

Showing results (441-450 of 469) with videos related to

Sort By:
Pageof 47
Frontiers in Cellular Neuroscience|November 23, 2017
Young Human Cholinergic Neurons Respond to Physiological Regulators and Improve Cognitive Symptoms in an Animal Model of Alzheimer's DiseaseAnnamaria Morelli, Erica Sarchielli, Giulia Guarnieri, et al.
Andrology|June 30, 2022
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohortRavinder Anand-Ivell, Kee Heng, Katie Severn, et al.
Plos One|July 19, 2012
Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetesGiovanni Di Pasquale, Ilaria Dicembrini, Laura Raimondi, et al.
Endocrinology|November 28, 2020
Insight on the Intracrinology of Menopause: Androgen Production within the Human VaginaIlaria Cellai, Vincenza Di Stasi, Paolo Comeglio, et al.
Reviews in Endocrine & Metabolic Disorders|June 3, 2024
Evidence-based definition of hypoprolactinemia in European men aged 40-86 years: the European male ageing studyThang S Han, Leen Antonio, György Bartfai, et al.
BJU International|July 14, 2016
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in MenFrans M J Debruyne, Hermann M Behre, Claus G Roehrborn, et al.
Molecular and Cellular Endocrinology|January 26, 2016
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbitsElena Maneschi, Ilaria Cellai, Antonio Aversa, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 6, 2023
Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European menNadjia Amini, Jolan Dupont, Laurence Lapauw, et al.
The Journal of Sexual Medicine|December 19, 2013
Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS)Giovanni Corona, Frederick C Wu, Giulia Rastrelli, et al.
The Journal of Sexual Medicine|July 3, 2009
The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunctionEmmanuele A Jannini, Andrea M Isidori, Giovanni Luca Gravina, et al.
Pageof 47